RE:For French speaking folks The article is based on an interview given by Paul Levesque to La Presse newspaper.
Must of the stuff discussed in it is already known by this board.
It is a good article,honest and upbeat; it reflects the enthousiastic mood Paul Levesque seems to be in when he discusses TH's cancer program and Nash. He uses words like ''spectacular '' , seldom seen''. '' fastrack not only for one tumor, but for all cancers'', ''incredible ''...
Concerning cancer, he expects the second part of phase 1 trial to start in the first quarter of 2022.
As for NASH, '' no partner yet, will cost $160 millions u.s.''
( rough translation )
''I would prefer having a partner, but we can't sit on a phase 3 protocol too long; we can't do that. It's incredible what we have achieved, we have to go ahead. Partner or not , the study will start in the first part of 2022 '' .
He expects to receive an approval in 5 years.
Again it is a good and positive article.